Price (delayed)
$8.62
Market cap
$324.07M
P/E Ratio
4.9
Dividend/share
N/A
EPS
$1.76
Enterprise value
$278.11M
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody,
There are no recent dividends present for TRDA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.